Episode Details

Shadd Dales and Anthony Varrell are joined by Beena Goldenberg, CEO of Organigram (NASDAQ: OGI), to discuss their latest earnings. Organigram reported a 17% increase in net revenue to $42.7 million for Q1 Fiscal 2025, up from $36.5 million in the same period last year. International sales grew by $2.3 million, and adjusted EBITDA rose to $1.4 million from $0.1 million.Additionally, Trent Woloveck, Chief Strategy Director from Jushi (OTC: JUSHF), will join us to talk about the new appointment of Terry Coleas the head of the DEA under the Trump administration. Jushi has a strong presence in the Virginia medical cannabis market, leveraging its background to build a relationship with the Cannabis Control Authority (CCA). This relationship became even more significant with Cole's appointment, as he previously served as Virginia's Secretary of Public Safety and Homeland Security.Together, they have worked on initiatives to ensure safe and effective cannabis use in Virginia.With Terry Cole's appointment as head of the DEA, Attorney General Pam Bondi will work closely with Cole to ensure that the Department of Justice (DOJ) aligns with the President's priorities, ultimately making decisions that focus on the administration's agenda. This approach aims to eliminate perceived biases and promote a unified strategy in line with Trump's vision.#dea#trump#trumpadministration#DOJ#CannabisRescheduling#Organigram#cannabis#marijuana#terrycole#pambondiWant to see more Cannabis Reform videos?   • Senate Banking, Cannabis Reform, and ...     • Why Derek Maltz was named Acting DEA ...     • Why Trump Won’t Sign Executive Order ...     • Will Trump Sign Executive Order for C...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:

Listen Now